ABT

Abbott Laboratories · NYSE:ABT

107.92 USD1.72 +1.62%

Abbott Laboratories (NYSE:ABT) last traded at 107.92 USD, up 1.62% on the day. Over the past year the stock is down 12.85%. Its 52-week range is 81.97 to 132.03. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open106.89

Day range106.40 – 108.56

52-week range81.97 – 132.03

Volume360.94 K

Average volume (10 days)9.36 M

Market cap186.75 B

P/E39.85

EPS (TTM)2.71

Dividend yield2.37%

Beta (1 year)−0.4600

Revenue (TTM)48.23 B

Employees115.00 K

Performance

+4.77%1 week

+10.98%1 month

+2.04%3 months

+23.27%6 months

−13.45%Year to date

−12.85%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.